Steven Glazer
BOARD MEMBER
healthcare and biotech
immunicum
Sweden
Biography
Steven Glazer is an experienced healthcare and biotech executive. He has extensive and broad therapeutic area experience including haematology, oncology, haemophiia, HIV, diabetes, allergic and cardiovascular disease from pharmaceutical and biotechnology companies in Europe and United States. He has a track record of successful planning and implementation of development, regulatory and corporate strategies, project and trial plans. Dr Glazer currently holds the position of Chief Medical Officer at Hansa Medical AB and served as Senior Vice President Development at BioInvent AB, Vice President Development at Zealand Pharma and Medical Director at Novo Nordisk. Steven holds a Doctor of Medicine from the University of Copenhagen and trained in Internal Medicine. Independence: Steven is independent from the Company and its management and its primary shareholders. Member of the Board since 2016.
Research Interest
healthcare and biotech
